| Value | ₹0.39 Cr |
|---|
NSE filing, NSE: VMM. Summary written from the filing by ALFA Finder's alert engine.
Vishal Mega Mart Ltd: key numbers
- Share price
- ₹87.95
- Market cap
- ₹41,203 Cr
- Revenue (annual)
- ₹12,906 Cr
- Net profit (annual)
- ₹839.2 Cr
- P/E (TTM)
- 45.9×Sector 61.5×
- Promoter holding
- 40.02%-0.07% QoQ
- FII holding
- 18.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vishal Mega Mart Ltd
All →Vishal Mega Mart Earnings Call Transcript: Key Takeaways
Vishal Mega Mart delivered 14% revenue growth despite a 3-4% festive shift impact. Management remains aggressive on store expansion but faces short-term operating deleverage from minimum wage hikes and festive timing.
Vishal Mega Mart Investor Presentation: Key Takeaways
Vishal Mega Mart reported Q2FY27 revenue of ₹3,398.5 Cr (up 14% YoY) with Adj. PAT of ₹172 Cr. Strategy focuses on store expansion and omni-channel growth via the 'Belong & Co' pilot.
Vishal Mega Mart Results Update
Vishal Mega Mart's Q2FY27 revenue rose 14% to ₹3,398.5 Cr; PAT ₹157.9 Cr. H1FY27 revenue hit ₹7,125.5 Cr, adding 49 net stores.
- total store count
- 844 stores
Vishal Mega Mart Q2 FY27 Results: Net Profit ₹157.9 Cr, Up 3.7% YoY
Vishal Mega Mart Ltd reported revenue from operations of ₹3,398 Cr (+14.0% YoY) and net profit of ₹157.9 Cr (+3.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹157.9 Cr · +3.7% YoY
Vishal Mega Mart Board Meeting Date
Vishal Mega Mart scheduled its Board meeting for 21 Oct 2026 to approve Q1/H1 results. The trading window remains closed until 48 hours post-announcement.
Vishal Mega Mart Other Announcement
Vishal Mega Mart Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.